The risk factors associated with PTC recurrence include extrathyroidal extension, LN metastasis, multifocal tumor, high postoperative thyroid-stimulating hormone, and high postoperative anti-thyroglobulin antibody level.[10,11]. This evidence concerns the gene TG and neoplasm.